Alhydrogel Brenntag

Tissue and Cell Extraction and Purification

EP10011 100 Tests
EUR 763.2

Alphabioregen Laboratories manufactures the alhydrogel brenntag reagents distributed by Genprice. The Alhydrogel Brenntag reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Alphabioregen. Other Alhydrogel products are available in stock. Specificity: Alhydrogel Category: Brenntag

JBS True Blue

300 µl
EUR 16
Description: JBS True Blue

True north Cryobox1.5/2mLNatural

PK10
EUR 129.6

True Blue Diaceturate Salt

100mg
EUR 15000
Description: 108321-12-6

True Blue (TB) Diaceturate Salt

1mg Ask for price
Description: 108321-12-6

True Blue (TB) Diaceturate Salt

5mg Ask for price
Description: 108321-12-6

Goat True insulin ELISA kit

96T
EUR 700
Description: ELISA

Porcine True insulin ELISA kit

96T
EUR 700
Description: ELISA

Serum / Plasma information

Anti-TNFRSF8 (Brentuximab)-VC-PABC-MMAE ADC

ADC-W-509 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody conjugated via a VC-PABC linker to MMAE

Anti-TNFRSF8 (Brentuximab )-MC-Vc-PAB-SN38 ADC

ADC-W-2346 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody conjugated via a MC-Vc-PAB linker to SN38

KRIBIOLISA Intact Brentuximab Vedotin ELISA

KBI1032 1 x 96 wells
EUR 2117.5

Anti-TNFRSF8 (Brentuximab-HC-K121)-DBCO-MMAF ADC

ADC-W-248 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,HC-K121) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-HC-Y180)-DBCO-MMAF ADC

ADC-W-249 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,HC-Y180) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-HC-K133)-DBCO-MMAF ADC

ADC-W-250 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,HC-K133) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-HC-S157)-DBCO-MMAF ADC

ADC-W-251 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,HC-S157) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-HC-F126)-DBCO-MMAF ADC

ADC-W-252 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,HC-F126) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-HC-P127)-DBCO-MMAF ADC

ADC-W-253 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,HC-P127) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-LC-R142)-DBCO-MMAF ADC

ADC-W-259 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-R142) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-LC-N152)-DBCO-MMAF ADC

ADC-W-260 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-N152) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 Brentuximab-LC-Q147)-DBCO-MMAF ADC

ADC-W-261 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-Q147) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-LC-E161)-DBCO-MMAF ADC

ADC-W-262 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-E161) conjugated via a DBCO linker to MMAF

Anti-TNFRSF8 (Brentuximab-LC-K149)-DBCO-MMAF ADC

ADC-W-263 1mg Ask for price
Description: This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-K149) conjugated via a DBCO linker to MMAF

Anti-CD30 (brentuximAbvedotin biosimilar) mAb

MBS188017-005mg 0.05mg
EUR 245

Anti-CD30 (brentuximAbvedotin biosimilar) mAb

MBS188017-01mg 0.1mg
EUR 320

Anti-CD30 (brentuximAbvedotin biosimilar) mAb

MBS188017-5x01mg 5x0.1mg
EUR 1135